Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis

This publication has 26 references indexed in Scilit:

• Regulatory Th2-type T cell Lines Against Insulin and GAD Peptides Derived from Orally- and Nasally-Treated NOD Mice Suppress Diabetes
  Journal of Autoimmunity, 1999
• Uveitogenicity Is Associated with a Th1-like Lymphokine Profile: Cytokine-Dependent Modulation of Early and Committed Effector T Cells in Experimental Autoimmune Uveitis
  Cellular Immunology, 1997
• In Vivo Administration of IL‐4 Induces TGF‐β‐producing Cells and Protects Animals from Experimental Autoimmune Encephalomyelitis
  Annals of the New York Academy of Sciences, 1996
• An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
  Immunity, 1995
• Anti‐IL‐10 Treatment Does Not Block Either the Induction or the Maintenance of Orally Induced Tolerance to Ova
  Scandinavian Journal of Immunology, 1995
• B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
  Cell, 1995
• Published by American Association for the Advancement of Science (AAAS) ,1994
• Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.
  The Journal of Experimental Medicine, 1994
• Interleukin-10-deficient mice develop chronic enterocolitis
  Cell, 1993
• STUDIES ON TRANSLOCATION OF IMMUNOGLOBULINS ACROSS INTESTINAL EPITHELIUM
  ACTA HISTOCHEMICA ET CYTOCHEMICA, 1976